论文部分内容阅读
经回顾性分析２４例川崎病患儿的临床疗效得出：用丙种球蛋白（ＩＶＩＧ＋ＡＳＰ）组冠状动脉损害发生率为８．３％，用阿斯匹林（ＡＳＰ）组为５０％。冠状动脉损害前者呈轻度扩张，后者表现为多发性扩张和巨大动脉瘤，提示早期使用大剂量丙种球蛋白是预防ＣＡＤ的首选药...
The clinical efficacy of 24 children with Kawasaki disease was retrospectively analyzed. The incidence of coronary artery lesions was 8.3% in IVIG + ASP group and 50% in aspirin group. The former showed mild coronary artery lesion expansion, the latter showed multiple expansion and huge aneurysms, suggesting early use of high-dose gamma globulin is the first choice to prevent CAD ...